Gallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cells

Chen, Chieh-HsinChieh-HsinChenHuang, Yi-MingYi-MingHuangLOUIS GRILLETHsieh, Yu-ChenYu-ChenHsiehYA-WEN YANGKAI-YIN LO2023-05-032023-05-032023-04-172211-34282211-3436https://scholars.lib.ntu.edu.tw/handle/123456789/630686Breast cancer is the most common cancer in women. Triple-negative breast cancer (TNBC) is an aggressive disease with poor outcomes. TNBC lacks effective targeted treatments, and the development of drug resistance limits the effectiveness of chemotherapy. It is crucial to identify new drugs that can enhance the efficacy of traditional chemotherapy to reduce drug resistance and side effects.enCisplatin; Ferroptosis; Gallium maltolate; Nucleolar stress; Triple-negative breast cancerGallium maltolate shows synergism with cisplatin and activates nucleolar stress and ferroptosis in human breast carcinoma cellsjournal article10.1007/s13402-023-00804-x370677472-s2.0-85153040211https://api.elsevier.com/content/abstract/scopus_id/85153040211